Sudden infant death syndrome

Sleep Disorders

Updated 07.05.2026
Released 02.13.1995
Expires For CME 07.05.2029

Sudden infant death syndrome

Authors: Sanjeev V Kothare MD FAES FAAN FAASM, Joel Willard MD

See Contributor Disclosures

Editor: Antonio Culebras MD FAAN FAHA FAASM

Cite this article

Sudden infant death syndrome

In This Article

Quick Link

Introduction

Overview

Sudden infant death syndrome (SIDS) is defined as the sudden, unexpected death of an infant under 1 year of age that remains unexplained after a thorough review of the clinical history, autopsy, and death scene investigation. SIDS falls under the broader category of sudden unexpected infant death (SUID), a term used to describe any unexpected death without an obvious cause occurring in children before their first birthday. In addition to SIDS, SUID encompasses other conditions such as asphyxia, arrhythmias, and accidental trauma. SIDS remains a leading cause of death among infants younger than 1 year of age, with 90% of cases occurring before 6 months of age. Although the exact etiology of SIDS is not known, the triple-risk model is the most widely accepted hypothesis. This model proposes that SIDS results from the interplay of risk factors from three domains: (1) a critical period of development, (2) an underlying vulnerability in the infant, and (3) an environmental trigger. Based on this framework, both risk factors and protective factors have been identified, forming the basis of recommendations aimed at preventing SIDS. In this article, the authors discuss the clinical presentation, pathophysiology, diagnostic workup, and current recommendations for SIDS (79).

Key points

	• SIDS is, by definition, a diagnosis of exclusion, assigned only when the cause of death remains unexplained after a thorough review of the clinical history, autopsy, and death scene investigation. If evidence of a specific cause of death is identified, the diagnosis of SIDS does not apply.
	• Sudden unexpected infant death (SUID) is a broader term encompassing unexpected deaths in infants younger than 1 year of age across various categories, including SIDS, asphyxia, arrhythmias, and accidental trauma.
	• SIDS affects infants under 12 months of age, with peak incidence between 2 and 4 months and declining frequency after 6 months. It is more common in boys and African American infants.
	• Although the exact etiology of SIDS remains unknown, it is thought to be associated with autonomic nervous system dysregulation and impaired arousal mechanisms.
	• Recommended preventative measures include placing infants on their backs to sleep; using a firm, non-inclined sleep surface free of extraneous soft bedding, clothing, toys, or positioning devices; breastfeeding; room sharing with parents without bed sharing; avoiding excessive room heat; avoiding exposure to cigarette or marijuana smoke, alcohol, opioids, and illicit drugs during pregnancy and after birth; and offering pacifiers.

Historical note and terminology

The concept of sudden infant death syndrome is thought to have existed since prehistoric times (46). The earliest recorded case potentially attributable to SIDS appears in the Old Testament (Bible: 1 Kings 3:19), though the infant's death was attributed to suffocation caused by overlying by its mother. To this day, distinguishing between accidental or intentional suffocation and SIDS remains difficult in the absence of overt signs of physical violence. In 19th-century Germany, pathologists devised explanations to defend mothers and nursemaids against accusations of overlying or infanticide. Initially, they attributed infant deaths to enlargement of the thymus, which they believed directly suffocated the infant, failing to recognize that the thymus is normally large during infancy (45). Later pathologists proposed that sudden death resulted from status thymicolymphaticus, a fictional constitutional disorder associated with alleged thymic hyperplasia, though no specific measurements were ever established.

At the Second International Conference on Causes of Sudden Death in Infants in 1969, Beckwith proposed a formal definition of SIDS as "the sudden death of any infant or young child which is unexpected by history, and in which a thorough postmortem examination fails to demonstrate an adequate cause of death" (09). This definition was further refined in 1989 by an expert panel convened by the National Institute of Child Health and Human Development, which specified an age limit of less than 1 year and incorporated death scene investigation. Some have recommended excluding the diagnosis of SIDS if the death scene has not been visited; however, this criterion alone should not preclude the diagnosis, as doing so would exclude approximately half of all probable cases (51). In 2004, a new definition known as "the San Diego classification" was proposed, introducing subcategories for SIDS cases. This classification has not been universally accepted, and modifications have been suggested (58). The need for a universally accepted definition is underscored by the results of a national survey of medical examiners and coroners, which revealed a lack of consensus in classifying deaths across four different SIDS case scenarios (105).

For many years, "apparent life-threatening event" (ALTE) was used to describe episodes that were frightening to the observer, typically involving apnea, color change, and marked alterations in muscle tone. In these events, the observer often feared that the infant had died or was about to die. ALTE was previously referred to as "near-miss SIDS"; however, evidence has since demonstrated that ALTE and SIDS are distinct entities and that ALTE does not increase the risk for SIDS. Consequently, the term near-miss SIDS is no longer used. Additionally, an underlying condition was ultimately identified in approximately 50% of infants who presented with ALTE. It is important to note that ALTE is inherently a subjective, observer-experienced event (21).

In 2016, the term "brief resolved unexplained event" (BRUE) was introduced as a replacement for ALTE in cases where no explanation for the event is found after a thorough history and physical examination, thereby incorporating an objective clinical assessment into the definition. BRUE is defined as an episode occurring in an infant younger than 12 months that is reported by the observer as brief (lasting less than 1 minute) and now resolved (with the infant returned to baseline), with normal vital signs, history, and physical examination at the time of evaluation by a medical provider. If the observed episode does not meet these criteria, further investigation is recommended. Infants with BRUE must be stratified into low-risk and high-risk categories. Published guidelines identify the following low-risk characteristics: age older than 60 days, gestational age greater than 32 weeks, postconceptional age greater than 45 weeks, no history of prior BRUE, event duration of less than 1 minute, no need for CPR, and no concerning findings on history or physical examination. High-risk infants include those younger than 2 months and with recurrent episodes, unstable vital signs, abnormal history or physical examination findings, or a prolonged event or an event requiring cardiopulmonary resuscitation (120).

The term "sudden unexpected infant death" has since emerged as an umbrella term encompassing all cases of sudden and unexpected death in infants younger than 1 year. SUID includes SIDS as well as deaths due to suffocation, trauma, asphyxia, entrapment, arrhythmia, metabolic conditions, and other causes (79).

Clinical manifestations

Presentation and course

	• There are no warning signs or symptoms for SIDS.
	• ALTE and BRUE have not been associated with SIDS.
	• High-risk BRUE infants should be identified to be appropriately evaluated.

Most victims of Sudden infant death syndrome appear healthy, free from significant health concerns, and asymptomatic prior to death. Minor respiratory and gastrointestinal symptoms, as well as impaired cardiovascular control, have been reported in some cases but are not thought to be causative of death. As such, SIDS remains a diagnosis of exclusion in the setting of sudden and unexpected infant death. Although no specific identifiers can predict SIDS, considerable attention has been directed toward identifying risk factors, which have been categorized in relation to the mother, the infant, and the environment. Maternal risk factors include young age, low socioeconomic status, higher parity, and tobacco or marijuana smoking. Infant-associated risk factors include genetics (such as being a sibling of an infant who died of SIDS), prematurity, male sex, small size for gestational age at birth, and sleep position (prone or lateral decubitus). Environmental risk factors include sleeping in car seats, soft bedding, bed sharing, and overheating.

Early autopsy findings in SIDS victims have been documented in the medical literature; however, none have been demonstrated consistently enough to be considered specific to SIDS. Several features have been described on autopsy, including intrathoracic petechiae (10); thyromegaly, encephalomegaly, microcardia, and light kidneys (Kelmanson 1992); and intracardiac unclotted blood, empty bladder, and mild fatty liver (12). Intrathoracic petechiae are present in approximately three fourths of victims. Although some pathologists have concluded that petechiae are specific to airway obstruction, this speculation is not supported by a majority of pathologists.

Histologic investigation in SIDS cases should include examination of the central nervous system (to distinguish nonspecific changes such as hyperemia and edema from findings indicative of meningitis, trauma, or malformations), the respiratory system (to differentiate nonspecific changes such as congestion and pleural hemorrhages from evidence of minor respiratory infection), and the myocardium (to rule out myocarditis or other cardiac causes of death) (05). Notably, over 50% of SIDS cases have associated respiratory infections (04). A separate review of 200 cases examining alternative histologic findings revealed that approximately 10% had identifiable causes of death, including pneumonia, aspiration, metabolic disorders, sepsis, and meningitis (70).

Prognosis and complications

Most SIDS cases occur during the first 6 months of life without warning or alerting symptoms, and there is no cure, as death is inherent to the syndrome. Although some risk factors and protective factors have been identified, neither ALTE nor BRUE has been associated with SIDS. The primary challenge for physicians is determining when an infant presenting with BRUE requires further workup, hospitalization, or monitoring for complications or recurrent events. Although most infants with ALTE or BRUE will follow a benign course without complications, 12% will require admission for further evaluation, and up to 24% will experience a recurrent episode (11).

An underlying condition is identified in approximately 50% of children with ALTE, with gastroesophageal reflux being the most common; other important conditions include seizures and respiratory infections (40).

Guidelines recommend that parents of infants with low-risk BRUE receive education and training in cardiopulmonary resuscitation and have scheduled follow-up visits. These infants can be discharged after a brief period of monitoring. In some instances, electroencephalography and pertussis testing may be indicated. High-risk infants with BRUE should be admitted for evaluation or treatment of the underlying condition (Moon and Task Force On Sudden Infant Death Syndrome 2022).

A 2023 study examining sibling recurrence in a Danish nationwide cohort of over 2.6 million births found that siblings of SIDS victims had a 4-fold higher risk of SIDS (SIR 4.27; 95% CI, 2.13-8.53) compared with the general population. This familial aggregation persisted beyond the back-to-sleep era, suggesting the involvement of shared genetic factors beyond environmental risk alone (42).

Clinical vignette

A family was enjoying their second-born son, who had been born full term and was now eating well, gaining weight appropriately, and in overall good health. A few days earlier, he had been seen by his pediatrician and found to be a healthy 3-month-old. At that visit, the pediatrician recommended that both parents quit smoking. One evening, the baby took his bottle of formula and was placed supine in his crib to sleep for the night, with a small stuffed toy, as was his usual routine. The parents slept well but were surprised that he had not cried during the night. When the mother came in to feed him, she was horrified to find him blue, cold, and not breathing. She immediately began administering mouth-to-nose respirations while the father called the paramedics, who arrived within 5 minutes. Unfortunately, the first responders were unable to resuscitate the infant. The baby was transported to the nearest hospital, where an autopsy was performed. The findings were unremarkable except for the presence of petechiae on the thymus and pericardium. Based on these findings, a diagnosis of SIDS was made.

The hospital connected the family with a local SIDS parents' group, which provided counseling and comfort as much as possible. The parents were told that it is impossible to predict SIDS but that recurrence in future children was unlikely. They later received the final autopsy report, which revealed no inherited disease and no serious infection; the unexplained and unexpected death was, therefore, classified as SIDS. The family's recovery from the grief of this tragedy was prolonged and difficult. Their physician advised them not to rush into another pregnancy, allowing time for both physical and emotional recovery.

Biological basis

Etiology and pathogenesis

	• The triple-risk hypothesis is commonly accepted.
	• The pathophysiology of SIDS is unknown.
	• Various pathophysiologic mechanisms have been postulated in SIDS, including respiratory, cardiac, and neurologic dysfunction.

Many theories regarding the mechanism of death in SIDS have evolved over the years.

The triple-risk hypothesis, a widely cited theory proposed in 1994 by Filiano and Kinney, suggests that SIDS results from the convergence of three factors:

	• An underlying vulnerability intrinsic to the infant, based on potential abnormalities in serotonergic signaling, arousal mechanisms, or cardiovascular reflexes.
	• An age-related risk corresponding to a critical period of development, based on known changes in cardiovascular response between 2 and 4 months of age.
	• Environmental stressors, based on studies and findings related to overheating, bed clothing, and sleep position.

Various physiologic mechanisms have been studied and proposed to explain infant deaths:

	• Respiratory dysfunction
	• Cardiovascular dysfunction
	• Central nervous system dysfunction
	• Neurotransmitter abnormalities
	• Altered immune response
	• Skeletal muscle abnormalities
	• Genetic abnormalities
	• Metabolic abnormalities
	• Association with epilepsy

Respiratory dysfunction. The normal hypoxic ventilatory response in infants follows a biphasic curve, with an initial augmentation in ventilation followed by a sustained reduction to levels similar to or below normoxic ventilation. This response is sustained in infants up to 6 months of age. Based on the hypothesis that a critical developmental period exists during which external exposures (such as abnormal oxygen levels or smoke) can permanently alter the system's final responses, the period between 2 and 4 months of age represents a critical window for ventilatory control. Abrupt changes in multiple neurotransmitters over short periods can also produce temporary instability in the ventilatory control system (72). Breathing regulation is governed by respiratory centers in the brainstem. Studies have shown that during the first months of life, infants exhibit an increased number of central apneas (average index of 10 events per hour), which may reflect immaturity of the respiratory centers. Lavezzi and associates have hypothesized that expression of the pontine Kölliker-Fuse nucleus (KFN), which plays a critical role in breathing control and sleep-wake transition, is defective and may contribute to sudden infant death (68).

One study demonstrated that healthy infants have an increased index of apneas and hypopneas (mean 14.9 per hour) during the first month of life (28), with nadir oxyhemoglobin saturations of 84.4%. This suggests that although infants may experience apneas secondary to immature respiratory centers, these events fall within expected parameters, are not associated with SIDS, and resolve quickly during the first months of life. It has also been hypothesized that the arousal response following apnea, rather than the apnea itself, may be the critical factor in SIDS. Apneas are typically terminated by an arousal or a gasp, which restores physiological parameters to levels of wakefulness or a lighter stage of sleep. A higher arousal threshold has been postulated as a possible contributor to SIDS. Notably, protective factors against SIDS, such as pacifier use and breastfeeding, are known to lower the arousal threshold, whereas cigarette smoking, high ambient temperatures, and infection are known to raise it, potentially prolonging the apnea and its associated gas exchange abnormality.

Cardiovascular dysfunction. Arrhythmias and cardiovascular disease have been suggested as potential causes of SIDS. Early studies reviewing electrocardiac data from first-degree relatives of SIDS victims found QT prolongation in 11 of 42 sets of parents (77), suggesting a heritable, long QT-associated cause of SIDS. The first direct electrocardiac evidence of long QT in SIDS victims came from a 1998 study by Schwartz and colleagues, which identified prolonged QTc (> 440 ms) in 12 of 24 SIDS victims within a cohort of 33,034 infants with 1-year follow-up data (103). Multiple studies have since investigated various mutations, with and without functional significance, in genes related to long QT syndrome, sodium channels, and potassium channels, as detailed in a review by Wilders (118). However, a functional gene study of one such mutation in hERG channels in a family with recurrent SIDS found that the mutation did not significantly alter channel expression or function (104). This finding highlights the implications of misdiagnosis based on the identification of a mutation without consideration of its functional effect, as well as the variability and penetrance of genetic mutations.

Other causes of sudden death proposed by Wilders include short QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT), such that "the prevalence of malignant cardiac ion channel-related mutations among SIDS victims may actually be close to 20%" (118). This concept is supported by a Danish study suggesting that up to 7.5% of a SIDS cohort (5/66) demonstrated genetic variations in sodium channel complex genes (119). A review by Evans and colleagues, however, showed no change in incidence when examining possible cardiac ion channel mutations implicated in SIDS (36). Additionally, Andreasen and colleagues found that many previously associated channelopathy gene variants were highly prevalent in the general population when analyzed using whole-exome data (03).

One group of researchers demonstrated genetic variants in sarcomere genes in children with sudden unexplained death using parallel sequencing of DNA, suggesting a possible correlation between SIDS and cardiomyopathy, though this link has not been definitively established (98).

In 2019, a study revealed that hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase subunit A (HADHA, tri-functional protein alpha) is required for fatty acid beta-oxidation and cardiolipin remodeling and is essential for functional mitochondria in human cardiomyocytes. Deficiency in this enzyme was found to result in MTP-deficient newborns who presented with SIDS, a condition that can manifest after birth once the child begins nursing on lipid-rich breast milk (80).

A 2026 study using next-generation sequencing of serum-derived extracellular vesicle microRNAs found that myocardial-specific miRNAs (miR-1, miR-208, miR-499) were markedly upregulated in SIDS cases compared to controls. Gene target prediction analyses implicated MAP signaling pathways, cardiomyocytes, and cardiac ion channels in SIDS pathogenesis, suggesting that cardiac injury may be a component of SIDS (60).

Central nervous system dysfunction. A small study investigating cerebellar microvessel length as a marker of chronic hypoxia found no difference between SIDS cases and controls (85). A separate study demonstrating cytoarchitectural alterations in both the auditory and respiratory centers of SIDS cases suggested a potential link in their development. Additional brainstem abnormalities described include delayed loss of dendritic spines in the reticular substance, subtle abnormalities of neurotensin binding sites, abnormalities in vagal nuclei, and decreased muscarinic receptor binding in the arcuate nucleus. Duncan and colleagues reported what they regarded as specific deficiencies in medullary serotonin (35) but did not consider that these deficiencies could have resulted from increased serotonin consumption during attempts to survive. Support for this interpretation comes from the presence of serotonin breakdown products in the spinal fluid of victims (20). Others found no correlation between pathologic data on serotonin and earlier physiologic studies of infants who subsequently died of SIDS (99). Evidence that the changes in the serotonergic system may represent depletion resulting from attempts to survive hypoxic injury is seen in the elevated interleukin-6 levels in the cerebrospinal fluid of SIDS victims and in the arcuate nucleus of the medullary 5-HT system (96). Furthermore, serotonergic system abnormalities in infants who died of SIDS have been associated with clinical risk factors, including smoking, bed sharing, and sleep position (71), rather than a prenatal cause as suggested by Paterson and colleagues (92). Guntheroth and colleagues concluded that it was not possible to prove or disprove that these abnormalities originated before birth and that the epidemiologic evidence favors a postnatal origin (49; 50; 100). Additionally, studies of infants who subsequently died of SIDS demonstrated no defects in ventilatory responsiveness during the first week of life (113); if brainstem abnormalities had occurred prenatally, neonatal testing should have revealed abnormal responsiveness during the first week of life rather than months later.

Neurotransmitter abnormalities. The serotonin deficiency theory has been a popular explanation for SIDS. A 2023 study provided the first detailed analysis of 5-HT2A/C receptor binding in the medulla of SIDS cases (n=58) compared with controls (n=12). Altered 5-HT2A/C binding was found in several key medullary nuclei, and in some nuclei, reduced 5-HT2A/C and 5-HT1A binding overlapped, suggesting abnormal serotonin receptor interactions across multiple receptor subtypes. These findings point to the existence of an integrative brainstem network involving both receptor types that may fail to facilitate arousal and autoresuscitation in SIDS cases (54). Kinney's work ties together the features of impaired autonomic function and respiratory control through the medullary serotonergic system (Kinney and Filiano 2001; 63). In 2025, Kinney and the Safe Passage Study cohort confirmed reduced 5-HT1A receptor binding in brainstem nuclei of infants who died of SIDS, replicating findings from prior cohorts. Additionally, the serotonin defect was strongly driven by preterm birth; premature infants who died of SIDS showed increased 5-HT1A binding compared to premature controls, suggesting that prematurity modifies the serotonergic defect in complex ways. A 2024 study demonstrated that platelet serotonin, 14-3-3, and glycoprotein IX (GPIX) are dysregulated in SIDS. Infants who died of SIDS had significantly higher intraplatelet 5-HT and 14-3-3 levels and lower platelet surface GPIX compared to controls; serum and plasma 5-HT were also elevated. These findings suggest multiorgan dysregulation of serotonin pathways and raise the possibility of using platelet biomarkers as predictive measures in living infants (39). Others, however, suggest that the deficiency more likely represents consumption of serotonin during the process of autoresuscitation (50; 107). Some studies have found no significant differences in serotonin transporter gene encoding or expression, or in serotonin breakdown products, when comparing SIDS cases and controls (88; 97). Although a definitive connection between SIDS and serotonin has not been established, the essential role of the 5-HT2A receptor in carbon dioxide-induced arousals illustrates why the field has maintained its interest in this pathway (17; 53; 54; 65).

An additional study by Huang and colleagues evaluated the expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and its complementary pituitary adenylate cyclase-activating polypeptide type 1 receptor (PAC1) in the brainstem, as these are known to function in central respiratory control (57). They found that compared with non-SIDS-related deaths, SIDS cases exhibited decreased expression of the PAC1 receptor in the arcuate nucleus of the rostral medulla. Because one of the functions of the arcuate nucleus is sensing carbon dioxide levels in the blood, lower PAC1 expression may contribute to a defective response to hypercapnic stress in infants who died of SIDS.

The neuropeptide substance P, which is implicated in respiratory rhythm generation and reflex responses to hypoxia, has also been studied in relation to SIDS. Bright and colleagues noted decreased neurokinin-1 receptor binding of substance P in SIDS cases compared with non-SIDS controls (16). Dysregulation of this mechanism is thought to affect both respiratory regulation and arousal responses, potentially contributing to the incidence of SIDS. However, this study was limited by its small sample size, and findings should be replicated to better understand their significance.

Impaired function of the orexin system has also been hypothesized as a possible contributor to SIDS. Although the exact mechanism has not yet been mapped, a study by Dergacheva and colleagues demonstrated that continued hypoxia- and hypercapnia-induced hyperpolarization was accompanied by rapid depression and then cessation of firing activity in orexin neurons. This type of orexin neuron depression has been observed in individuals with obstructive sleep apnea and SIDS (34).

Altered immune response. Histologic evidence of minor respiratory infection is present in most SIDS autopsies, and viral isolates can be obtained at a rate several times higher than that seen in living controls. The role of infection and an enlarged thymus has been revisited in a study comparing the weight of the thymus in infant SIDS victims with that of controls who died of trauma (44).

Several studies have found an association between the anti-inflammatory cytokine interleukin-10 and SIDS (31), suggesting that these victims may mount an inadequate inflammatory response to infection. The genetic pathway to this cytokine has been examined, but no association with SIDS has been found (27).

Studies from Norway and Germany investigated the C4 gene in SIDS victims. Neither study detected differences in gene frequencies between SIDS and control cases. However, both showed an association between mild infection before death and partial deletions of either the C4A or C4B gene, suggesting that this combination may increase the risk of SIDS (102; 89). Partial deletions of the C4 gene are relatively common, found in up to 20% of the Caucasian population (87).

Because minor infectious diseases are associated with SIDS, maintaining the routine vaccination schedule is recommended for all infants. A meta-analysis demonstrated that immunizations are actually associated with a halving of the risk of SIDS (112).

A 2024 multiomic study identified human parechovirus 3 (HPeV3) infection via metagenomic next-generation sequencing in a SIDS case with elevated CSF neopterin; 9.3% of SIDS cases had elevated neopterin, suggesting neuroinflammation. Single-nucleus RNA sequencing of HPeV3-positive brainstem tissue revealed dramatic cell-type-specific inflammatory responses, with profound molecular changes in vascular cells (endothelial cells and pericytes), astrocytes, oligodendrocytes, and microglia. Interferon-induced genes were strikingly upregulated, whereas genes associated with neuronal development showed reduced expression. This demonstrates that next-generation molecular tools can reveal occult infections and neuroinflammation that are undetectable by standard autopsy (93).

A 2025 French interrupted time-series study provided further evidence for a role of infection in a subset of sudden unexpected death in infancy (SUDI), finding a significant decrease in infection-related SUDI incidence during the COVID-19 pandemic (adjusted IRR 0.83; 95% CI, 0.72-0.96). SUDI cases without pathogen identification did not change in frequency (101).

Skeletal muscle abnormalities. Evidence has implicated sodium channelopathies in skeletal muscle in SIDS cases. Researchers have identified rare mutations in the SCN4A gene, which encodes the NaV1.4 voltage-gated skeletal muscle sodium channel, in SIDS cases that were not found in matched controls (76). Both gain-of-function and loss-of-function mutations in the SCN4A gene have previously been implicated in neurologic disorders such as myotonia and congenital myasthenic syndrome. The NaV1.4 channel is thought to be crucial for the function of fast-twitch respiratory muscles, particularly under conditions such as hypoxia that place increased demand on these muscles. Although Mannikko and colleagues conducted functional gene studies and noted decreased current density in the mutated gene, these studies were performed only in vitro and require further investigation for clinical significance.

Genetic abnormalities. The possibility of polygenic or polymorphic contributions to SIDS cannot be dismissed, given the 50% excess of males among SIDS victims and in deaths from respiratory illnesses and congenital heart disorders that result in severe hypoxia. Mage and Donner hypothesize the common factor to be terminal hypoxia with failure to protect against cerebral anoxia, arising from a dominant allele on an X-linked gene (73). Their model also predicts the 25% male excess for all infant and child mortality during the first 5 years of life. From the perspective of Mendelian inheritance, however, there is no evidence that SIDS is familial, considering the recurrence rate of only 1.3% (47), which suggests a stronger role for de novo mutations. Based on epidemiologic and pathologic findings, genetic studies have focused on the serotonergic system, the nicotinic system (given its link to tobacco smoke exposure), the autonomic nervous system, particularly as it relates to impairment in cardiorespiratory function, including cardiac channelopathies (with SCN5A being the most prevalent), and inflammation. Ferrante and colleagues further support a possible genetic mutation link in SIDS, with findings indicating that compared to controls, SIDS cases exhibit altered expression of a number of genes involved in the inflammatory process (37).

A 2023 molecular autopsy study examining 25 definitive-evidence arrhythmia-associated genes found that the yield of likely pathogenic variants was higher in sudden unexplained death in childhood (SUDC, 18.8%) than in SIDS (2.6%) (67).

A 2024 whole-genome sequencing study of 144 SUID infants identified variants of interest in 88 genes in 64.6% of cases. Forty-three cardiac genes related to cardiomyopathies and arrhythmias were implicated; 22 genes were associated with neurologic functions; and, notably, eight genes involved in hypoxia response and reactive oxygen species regulation were newly described. Seventy-two infants met the triple-risk hypothesis criteria (07).

A 2025 Dutch study of genetic evaluation in SUDI/SUDC found a 20% to 28% prevalence of likely pathogenic variants, with the highest yield (28%) in cases where routine postmortem examination failed to identify a cause of death. Both cardiac (8%) and noncardiac (5%) genetic pathways were implicated.

Metabolic abnormalities. A 2016 systematic review by van Rijt and colleagues found that sudden infant death was associated with 43 inborn errors of metabolism, with treatment available for at least 32 of these conditions. Twenty-six can be identified via newborn screening, but 26 can also present during the neonatal period, meaning symptoms may begin before screening results are available (111). A 2024 case-control study confirmed that newborn screening metabolites, particularly acylcarnitines, are associated with SIDS risk (90).

Association with epilepsy. Sudden unexpected death in epilepsy (SUDEP) is defined as a sudden, unexplained death in a person with epilepsy not attributable to trauma, drowning, or toxicological causes, with an incidence in children of 1.2 per 1,000 person-years (84; 59). The mechanisms underlying pediatric SUDEP share striking parallels with SIDS. Both conditions appear to converge on a final common pathway involving brainstem serotonergic dysfunction, impaired arousal, and cardiorespiratory failure. Medullary 5-HT neurons that stimulate breathing and arousal in response to hypercapnia are inhibited during seizures, and reduced 5-HT1A and 5-HT2A/C receptor binding has been demonstrated in both entities. Genetic overlap is increasingly recognized, with cardiac ion channel genes (eg, SCN5A, KCNQ1) implicated in both SIDS and seizure-induced cardiac dysfunction. Buerki and colleagues analyzed whole-exome sequencing data from 155 SIDS cases and 45 sudden unexplained death cases, focusing on 365 epilepsy-related genes, and identified an increased incidence of pathogenic or likely pathogenic variants in several epilepsy genes, including OPA1, RAI1, SCN3A, SCN5A, and TSC2 (18). Bard and colleagues performed whole-genome sequencing on 144 SUID cases and identified variants of interest in 88 genes across 64.6% of the cohort, of which 22 genes were associated with neurologic functions, including epilepsy-related genes, alongside 43 cardiac genes (07). Barranco and colleagues proposed that SIDS, sudden arrhythmic death syndrome (SADS), and SUDEP may represent "three sides of the same pyramid," sharing overlapping pathophysiological mechanisms and autopsy findings (08).

Epidemiology

	• The rate of SIDS has declined over time, likely due to both the implementation of prevention measures and the reclassification of cases where specific etiologies have been identified.
	• There are increased risk factors for SIDS.
	• There are preventive factors for SIDS.

SIDS rates have declined considerably, from 130.3 deaths per 100,000 live births in 1990 to 35.2 deaths per 100,000 live births in 2018. This decline is largely attributed to the "Back to Sleep" campaign, which focuses on preventing SIDS by recommending that parents place infants on their backs to sleep. Although the incidence is typically considered to be less than one per 1,000 live births, it is on average two to three times higher in African American and American Indian/Alaska Native populations. The rate has also been found to be disproportionately higher in childcare settings, accounting for 15% to 20% of cases, and is more common in boys (odds ratio 1.49). The occurrence of SIDS peaks between 2 and 4 months of age, diminishes rapidly thereafter, and is uncommon after 6 months.

Different risk factors in the sleep environment have been identified in younger infants aged 0 to 3 months (bed sharing, sleeping in an adult bed) compared with the 4-month-and-older population (objects present in the sleeping environment) (26). By consensus, 12 months of age is regarded as the upper limit for inclusion.

On average, SIDS victims tend to be smaller than normal infants and prematurely born. Small-for-gestational-age infants carry a slightly increased risk of SIDS, whereas other residual abnormalities resulting from prematurity confer a 2.5-fold greater risk, with the increase primarily observed in preterm infants born between 24 and 28 weeks (75; 74).

The risk of SIDS is strongly influenced by the infant's sleep position, with the highest risk associated with the prone position and the lowest risk with the supine position (32; 48). Prone sleeping increases the amount of time spent sleeping, particularly in quiet sleep, and reduces both spontaneous arousal and arousal to a variety of stimuli (56). Moreover, a study from Tasmania showed that the risk of SIDS associated with prone sleeping increased 10-fold in the presence of a concurrent infection (117), and a Nordic study demonstrated a 29-fold increase in risk when prone positioning was combined with infection (55; 29).

In addition to sleep position, sleep location has been associated with SIDS. Rechtman and colleagues demonstrated that 12.9% of a SIDS cohort was sleeping on a sofa, and these deaths were also associated with additional risk factors, including prenatal tobacco smoke exposure, sleep surface sharing, and a new sleep location (94). Altitude has also been associated with an increased risk of SIDS (OR 2.3; 95% CI, 1.01-5.24) (61).

Maternal smoking is associated with a doubling of the risk for sudden infant death. A meta-analysis found that the risk is related to both pre- and postnatal maternal smoking and appears to be dose dependent (121). A potential pathway for this finding is suggested by a study demonstrating impaired chemoreception in neonatal rats exposed to cigarette smoke, though this effect was observed only under acidotic conditions (69). The risk associated with prenatal cigarette smoke exposure, as with the risk associated with alcohol or drug use, is further increased when combined with bed sharing (23). Infants of substance-abusing mothers are also at substantial risk. The infants of women on methadone programs have an increased risk of SIDS, particularly if the mother smokes (19). Along these same lines, hypoxic challenges in neonates demonstrated alterations in minute volume in children with either cigarette smoke exposure or substance abuse (02). One study showed that 12 of 32 (37.5%) SIDS cases in a cohort were born to mothers who used methadone or other drugs of abuse during pregnancy (24). The presence of additional SIDS risk factors in these cases, however, made it difficult to determine how much of an impact drug exposure had independently. This highlights the importance of identifying and educating parents who use drugs about limiting additional risk factors in their high-risk infants.

Infants who die of SIDS tend to be formula-fed rather than breastfed. A large meta-analysis across eight countries studying 2,267 SIDS cases and 6,837 controls suggested a minimum of 2 months of breastfeeding for protective effects against SIDS (109).

The great majority of SIDS victims are asleep at the time of death. Two exceptions are infants with gastroesophageal reflux and those with seizure disorders, which typically produce prolonged apnea. Sedatives or tranquilizers in cough suppressants have been found to increase the risk of SIDS, presumably by depressing arousal (95).

Heat stress has been implicated in several studies (78). The head is a major heat exchanger, and covering the head produces a remarkably high odds ratio for sudden infant death (38).

Bed sharing has been implicated in infant deaths for centuries, with the usual inference being that the infant suffocated from being overlain. Sofa sharing is a particularly risky form of bed sharing (78), made worse by alcohol or drug use before co-sleeping (13). It has additionally been postulated that the mechanism of death differs in co-sleeping infants compared with those sleeping alone, based on higher levels of medullary astrogliosis observed in alone sleepers (106). Astrogliosis is a marker of injury that accumulates over time, suggesting that the mechanism of death in co-sleeping infants, such as accidental suffocation, is a rapid process that does not allow time for reactive astrogliosis to develop.

A 2025 review in American Family Physician emphasized that although SIDS incidence has decreased since the Back to Sleep campaign, overall sudden unexpected infant death rates have plateaued. The apparent decline in SIDS likely reflects improved death investigations and diagnostic reclassification rather than a true decrease in unexplained deaths (30).

Prevention

	• Infants must sleep on their backs.
	• The sleeping environment must include room sharing but not bed sharing, use of a firm noninclined sleep surface, and no loose bedding. Sleep surfaces should comply with updated Consumer Product Safety Commission rules.
	• Supervised, awake tummy time is recommended beginning soon after hospital discharge, increasing to at least 15 to 30 minutes daily by 7 weeks of age.
	• Breastfeeding is recommended.
	• No tobacco or marijuana smoking, alcohol, opioids, or illicit drugs are allowed during pregnancy and after birth.
	• Offer the infant a pacifier at naptime and bedtime.
	• Avoid overheating.
	• Seek prenatal care.
	• Immunize the infant according to American Academy of Pediatrics recommendations.
	• Swaddles should not be used after the infant shows signs of attempting to roll over.

Several epidemiologic studies have identified risk factors for SIDS, many of which are amenable to intervention. A full list of recommendations is provided in alphabetical order in Table 1. The American Academy of Pediatrics released an updated policy statement in 2016 and again in 2022, reaffirming many of these recommendations and expanding guidance on maternal substance use, the sleeping environment, swaddling, and tummy time (82; Moon and Task Force On Sudden Infant Death Syndrome 2022).

Judging by the dramatic decrease in SIDS rates in most countries that have implemented "Back to Sleep" campaigns, prone sleeping is the single most important risk factor amenable to intervention. Although the overall incidence of SIDS has decreased significantly with the "Back to Sleep" campaign, racial disparities in SIDS rates persist, with higher rates found in American Indian and Alaska Native populations, followed by non-Hispanic Black and Hispanic populations; the lowest rates are found among Asians and Pacific Islanders (91). Similar campaigns targeting sleep location rather than position have been far less successful, likely due to social and cultural differences (06).

Another preventive factor is the use of a pacifier, particularly for formula-fed infants (81). The mechanism by which pacifiers reduce the risk for SIDS has not been established, but a New Zealand study found that pacifiers produce a small but significant forward displacement of the jaw, which may protect the upper airway in a manner similar to mouthpieces used for obstructive airway disorders in adult sleep apnea (110).

The American Academy of Pediatrics recommends against the use of home cardiorespiratory monitors in infants, as they have not been shown to decrease the incidence of SIDS. Routine in-hospital cardiorespiratory monitoring before discharge has also not been demonstrated to detect infants at risk for SIDS. There are no data supporting the use of any commercial devices designed to monitor infant vital signs to reduce the risk of SIDS.

Smartphone-integrated consumer baby monitors that measure vital signs are not regulated by the U.S. FDA. A 2017 study assessed the accuracy of pulse oximetry-based consumer baby monitors by comparing them with an FDA-cleared oximeter (15). Two consumer baby monitors using pulse oximetry were evaluated in hospitalized infants aged 0 to 6 months on general pediatrics and cardiology services who were born after 34 weeks of gestation, were not critically ill, not anemic, not febrile, and had stable vital signs. The first monitor detected hypoxemia (sensitivity 88.8%, specificity 85.7%) but performed inconsistently, whereas the second monitor never detected hypoxemia and also displayed falsely low pulse rates (sensitivity and specificity for hypoxemia were 0.0% and 100.0%, respectively; for bradycardia, 0.0% and 82.3%, respectively) (15).

Another important intervention in the prevention of SIDS is education through preventive campaigns. The "Back to Sleep" campaigns have proven to be highly effective. Pediatricians and other healthcare professionals, beginning with staff in newborn nurseries and neonatal intensive care units, should educate parents on the recommendations listed in Table 1 (108).

Table 1. Risk Factors Potentially Amenable to Intervention in SIDS

Risk factor	Intervention suggested
Arousal depressed in infant	Avoid sedatives, sleep deprivation
Bed sharing	Crib for infant in room with adult
Cigarette smoking	Smoking cessation
Failure to recognize illness or cyanosis	Baby sleeps supine in crib located in parents’ bedroom
Formula feeding	Breastfeeding*
Hypoxia in premature infants	Oxygen supplement for low saturations at home
Immunization failure	Immunize infants*
Infections, particularly febrile	Identification and treatment of underlying cause
Maternal depression	Diagnosis and treatment*
Not using pacifiers	Consider use of pacifiers
Pillows, stuffed animals, positioning devices, or heavy blankets in bed	Avoid
Poverty, uneducated mothers	Addressing disparities, maternal education*
Prenatal care absent or late	Early care (direct effect)*
Prolonged apnea	Work-up including EEG, polysomnography, evaluation for gastroesophageal reflux
Prone or side sleep position, especially if novel for the infant	Supine sleep position, always
Short inter-pregnancy interval	Pregnancy interval greater than 6 months*
Sleep	Avoid sleep disruption or deprivation, and encourage a regular infant sleep schedule
Substance abuse, maternal	Avoidance, counseling*
Thermal stress: excess insulation, heated room, head covered	Avoid
Young, unwed, multiparous mother	Contraception, sex education
* Designates interventions that reduce all infant mortality

Diagnostic workup

	• The diagnostic workup in the evaluation of victims of SIDS includes a full clinical history.
	• The full report from first responders provides valuable information about the environment and circumstances of the infant’s death.
	• Autopsy, including laboratory workup, is mandatory.

Because SIDS is a diagnosis of exclusion, it requires an extensive investigation into the cause of death. A thorough evaluation should include a detailed clinical history obtained from caregivers, a complete review of the medical records, an investigation of the time and place of death, and an autopsy performed within 24 hours of death.

Clinical history. The clinical history should encompass a full prenatal, birth, and family history, along with an assessment of risk factors, such as infant sleeping position and co-sleeping. Social determinants of health, including home structure, environment, and access to medical care, should also be documented.

Autopsy. The examination of the child should include a comprehensive assessment for potential injuries, congenital abnormalities, infection, and metabolic defects. Autopsy identifies the cause of death in only approximately 15% of cases. Radiologic testing, metabolic screening, microbiology, and toxicology should be performed. Advanced techniques such as metagenomic next-generation sequencing (mNGS), single-nucleus RNA sequencing (snRNAseq) of brainstem tissue, and serum-derived extracellular vesicle miRNA analysis have demonstrated the ability to reveal occult etiologies not apparent on standard autopsy; however, these modalities may not be available at most institutions.

Death scene investigation. This component of the evaluation should begin with a report from the first responders who arrived at the scene. First responders can assess the environment, including temperature, ventilation, the home setting, clothing, bedding, and the infant’s location (such as on the floor, a sofa, or a parent's bed) (33).

Management

Outcomes

	• There is no treatment for SIDS.
	• Management is aimed toward care and support of the family.
	• Education of caregivers and healthcare workers is important for the prevention of SIDS.
	• Future research is needed.

There is no treatment for SIDS, as death is the defining outcome. The primary focus is, therefore, on providing care and support to the family who has lost a child, as the grief that follows can be prolonged and difficult. For most families, support from healthcare professionals and relatives is sufficient to help during this period of bereavement (14). However, approximately 10% to 15% of parents may experience serious disruption in emotional stability, which can lead to poor physical and psychosocial outcomes (86; 116).

A 2020 review identified five overarching components of bereavement interventions: (1) acknowledgment of parenthood and the child's life, (2) establishing keepsakes, (3) follow-up contact, (4) education and information, and (5) remembrance activities (66). A limitation of the reviewed studies is that although they described their methodologies, experience, and specific interventions, no data on efficacy were provided. Because most interventions lacked empirical evidence, they were evaluated against key theoretical concepts, which demonstrated that all components had a theoretical basis. The authors concluded that interventions should focus on the continuous transition process parents experience as they readjust to a new reality (66).

A 2020 study found that 98.6% of bereaved mothers who lost a child to SIDS reported having transitional objects of grief, such as saved belongings of their deceased child (43). Mothers diagnosed with prolonged grief disorder visited these transitional objects more frequently and experienced greater distress, particularly when visiting them privately. However, mothers with prolonged grief disorder who felt comforted by the objects had a lower risk of finding life meaningless or finding discussion about the infant intolerable. Further research is needed to understand the potential therapeutic use of transitional objects in promoting bereavement adjustment (43).

To prevent SIDS, multiple efforts have been made to educate medical personnel and parents about infant safe sleep practices. These efforts have included educational videos and brochures, modeling safe sleep practices in the hospital, enforcing hospital safe sleep policies, computer-based training, and written and visual instructions for parents and healthcare workers (114). Despite these interventions, a 2017 survey of 3,297 mothers from 32 U.S. hospitals revealed that many still reported having received either no advice or incorrect advice regarding safe sleep practices (25). Additionally, none of these studies included trained participants who were tasked with arranging a completely safe sleep environment or used a predetermined performance criterion to objectively assess their knowledge (114).

Indirect measures such as self-report or questionnaires were used to assess the effectiveness of interventions, which can be problematic, as participants may report increased knowledge or adherence to safe sleep practices without being able to demonstrate this in practice (01). Direct measurement of behavior, therefore, appears to be a more effective strategy for evaluating intervention effectiveness.

To address this issue, researchers have proposed behavioral skills training as a possible strategy. Behavioral skills training is an evidence-based teaching approach that involves instructions, modeling, rehearsal, and feedback. To enhance its applicability, a simulation environment may be used to approximate a naturalistic setting. The use of behavioral skills training has demonstrated more robust outcomes compared to traditional educational approaches (41). In a 2020 study, behavioral skills training significantly improved the appropriate arrangement of a safe sleep environment for eight infants (22). Notably, however, the participants were students rather than parents or caregivers, and the small sample size limits the generalizability of these results. Regardless, these data provide valuable insights that warrant further investigation in a larger and more representative group of participants.

Future research on SIDS remains essential to advancing our understanding and supporting evidence-based recommendations, better educating parents and healthcare workers, and focusing efforts on strategic action. The Global Action and Prioritization of Sudden Infant Death Project was an international consensus initiative aimed at guiding future research. The three main themes among the priorities identified are: (1) better understanding of the mechanisms underlying sudden unexpected infant death, (2) ensuring best practices in data collection, management, and sharing, and (3) achieving a better understanding of target populations and more effective communication of risk (52).

The BIOMINRISK protocol represents a systematic effort to develop predictive biomarkers across genetic, neurobiological, and anatomical domains that may eventually translate into clinical tools for risk stratification of living infants, informing targeted monitoring and prevention strategies.

References

01: Ahlers-Schmidt CR, Kuhlmann S, Kuhlmann Z, Schunn C, Rosell J. To improve safe sleep practices, more emphasis should be placed on removing unsafe items from the crib. Clin Pediatr 2014;53:1285-7. PMID 24419267
02: Ali K, Rossor T, Bhat R, et al. Antenatal substance misuse and smoking and newborn hypoxic challenge response. Arch Dis Child Fetal Neonatal Ed 2016;101(2):F143-8. PMID 26290480
03: Andreasen C, Refsgaard L, Nielsen JB, et al. Mutations in genes encoding cardiac ion channels previously associated with sudden infant death syndrome (SIDS) are present with high frequency in new exome data. Can J Cardiol 2013;29(9):1104-9. PMID 23465283
04: Bajanowski T, Rolf B, Jorch G, Brinkman B. Detection of RNA viruses in sudden infant death (SID). Int J Legal Med 2003;117(4):237-40. PMID 12750907
05: Bajanowski T, Vege A, Byard RW, et al. Sudden infant death syndrome (SIDS)--standardized investigations and classification: recommendations. Forensic Sci Int 2007;165(2-3):129-43. PMID 16806765
06: Ball HL, Volpe LE. Sudden Infant Death Syndrome (SIDS) risk reduction and infant sleep location - moving the discussion forward. Soc Sci Med 2013;79:84-91. PMID 22571891
07: Bard AM, Clark LV, Cosgun E, et al. Known pathogenic gene variants and new candidates detected in sudden unexpected infant death using whole genome sequencing. Am J Med Genet A 2024;194(11):e63596. PMID 38895864
08: Barranco R, Caristo I, Molinelli A, Rocca G, Vernazza N, Ventura F. Update on the similarities between SADS, SIDS, and SUDEP: Three sides of the same pyramid? Int J Legal Med 2026;140(1):1-12. PMID 41062843
09: Beckwith JB. Discussion of terminology and definition of the sudden infant death syndrome. In: Bergman AB, Beckwith JB, Ray CG, editors. Sudden infant death syndrome: proceedings of the Second International Conference on the Causes of Sudden Death in Infants. Seattle, WA: University of Washington Press, 1970:14-22.
10: Beckwith JB. Intrathoracic petechial hemorrhages: a clue to the mechanism of death in sudden infant death syndrome. Ann N Y Acad Sci 1988;533:37-47. PMID 3048177
11: Behnam-Terneus M, Clemente M. SIDS, BRUE, and Safe Sleep Guidelines. Pediatr Rev 2019;40(9):443-55. PMID 31477587
12: Berry PJ. Pathological findings in SIDS. J Clin Pathol 1992;45(11 Suppl):11-6. PMID 1474151
13: Blair PS, Sidebotham P, Evason-Coombe, et al. Hazardous co-sleeping environments and risk factors amenable to change: case-control study of SIDS in south west England. BMJ 2009;339:b1136. PMID 19826174
14: Boelen PA, Smid GE. Disturbed grief: prolonged grief disorder and persistent complex bereavement disorder. BMJ 2017;357:j2016. PMID 28522468
15: Bonafide CP, Localio AR, Ferro D, et al. Accuracy of pulse oximetry-based home baby monitors. JAMA 2018;320(7):717-9. PMID 30140866
16: Bright FM, Vink R, Byard RW, Duncan JR, Krous HF, Paterson DS. Abnormalities in substance P neurokinin-1 receptor binding in key brainstem nuclei in sudden infant death syndrome related to prematurity and sex. PLoS One 2017;12(9):e0184958. PMID 28931039
17: Buchanan GF, Smith HR, MacAskill A, Richerson GB. 5-HT2A receptor activation is necessary for CO2-induced arousal. J Neurophysiol 2015;114(1):233-43. PMID 25925320
18: Buerki SE, Haas C, Neubauer J. Exome analysis focusing on epilepsy-related genes in children and adults with sudden unexplained death. Seizure 2023;113:66-75. PMID 37995443
19: Burns L, Conroy E, Mattick RP. Infant mortality among women on a methadone program during pregnancy. Drug Alcohol Rev 2010;5:551-6. PMID 20887580
20: Cann-Moisan C, Girin E, Giroux JD, et al. Changes in cerebrospinal fluid monomine metabolites, tryptophan, and gamma-amino-aminobutyric acid during the first year of life in normal infants: comparison with victims of sudden infant death syndrome. Biol Neonate 1999;75:152-9. PMID 9925902
21: Carbayo Jimenez T, Cedena Romero P, Gimeno Sánchez I. [Replacing «apparent life threatening event» (ALTE) with «brief resolved unexplained event» (BRUE). A retrospective review of the ALTEs that meet the criteria of a BRUE]. An Pediatr (Barc) 2020;93(4):261-2. PMID 32094090
22: Carrow JN, Vladescu JC, Reeve SA, Kisamore AN. Back to sleep: teaching adults to arrange safe infant sleep environments. J Appl Behav Anal 2020;53(3):1321-36. PMID 31997368
23: Carpenter R, McGarvey C, Mitchell EA, et al. Bed sharing when parents do not smoke: is there a risk of SIDS. An individual level analysis of five major case-control studies. BMJ Open 2013;3(5). PMID 23793691
24: Cohen MC, Morley SR, Coombs RC. Maternal use of methadone and risk of sudden neonatal death. Acta Paediatr 2015;104(9):883-7. PMID 26011156
25: Colson ER, Geller NL, Heeren T, Corwin MJ. Factors associated with choice of infant sleep position. Pediatrics 2017;140(3):e20170596. PMID 28827382
26: Colvin JD, Collie-Akers V, Schunn C, Moon RY. Sleep environment risks for younger and older infants. Pediatrics 2014;134(2):e406-12. PMID 25022735
27: Courts C, Madea B. No association of IL-10 promoter SNP-592 and –1082 and SIDS. Forensic Sci Int 2011;204(1-3):179-81. PMID 20591588
28: Daftary AS, Jalou HE, Shively L, Slaven JE, Davis SD. Polysomnography reference values in healthy newborns. J Clin Sleep Med 2019;15(3):437-43. PMID 30853051
29: Daltveit AK, Irgens LM, Oyen N, Skjaerven R, Markestad T, Wennergren G. Circadian variations in sudden infant death syndrome: associations with maternal smoking, sleeping position and infections. The Nordic Epidemiological SIDS Study. Acta Paediatr 2003;92(9):1007-13. PMID 14599060
30: Darrow HJ, Carman KA, Wheeler V. Sudden infant death syndrome: common questions and answers. Am Fam Physician 2025;111(2):164-70. PMID 39964928
31: Dashash M, Pravica V, Hutchinson IV, Barson AJ, Drucker DB. Association of sudden infant death syndrome with VEGF and IL-6 gene polymorphisms. Hum Immunol 2006;67(8):627-33. PMID 16916659
32: de Jonge GA, Engelberts AC, Koomen-Liefting AJ, Kostense PJ. Cot death and prone sleeping position in the Netherlands. BMJ 1989;298:722. PMID 2496821
33: Delteil C, Meyronet D, Maues de Paula A, Jouvet A, Piercecchi-Marti MD. [Neuropathology of sudden infant death syndrome: review of the literature and proposal of a protocol for neuropathological examination]. Ann Pathol 2018;38(2):103-9. PMID 29429858
34: Dergacheva O, Yamanaka A, Schwartz AR, Polotsky VY, Mendelowitz D. Hypoxia and hypercapnia inhibit hypothalamic orexin neurons in rats. J Neurophysiol 2016;116(5):2250-9. PMID 27559138
35: Duncan JR, Paterson DS, Hoffman JM, et al. Brainstem serotonergic deficiency in sudden infant death syndrome. JAMA 2010;303:430-7. PMID 20124538
36: Evans A, Bagnall RD, Duflou J, Semsarian C. Postmortem review and genetic analysis in sudden infant death syndrome: an 11-year review. Hum Pathol 2013;44(9):1730-6. PMID 23623143
37: Ferrante L, Rognum TO, Vege À, Nygárd S, Opdal SH. Altered gene expression and possible immunodeficiency in cases of sudden infant death syndrome. Pediatr Res 2016;80(1):77-84. PMID 26959483
38: Fleming PJ, Blair PS, Bacon C, et al. Environment of infants during sleep and risk of the sudden infant death syndrome: results of the 1993-5 case-control study for confidential inquiry into stillbirths and deaths in infancy. Confidential Enquiry into Stillbirths and Deaths Regional Coordinators and Researchers. BMJ 1996;313(7051):191-5. PMID 8696193
39: Frelinger AL, Haynes RL, Goldstein RD, et al. Dysregulation of platelet serotonin, 14-3-3, and GPIX in sudden infant death syndrome. Sci Rep 2024;14(1):11092. PMID 38750089
40: Fu LY, Moon RY. Apparent life-threatening events: an update. Pediatr Rev 2012;33(8):361-9. PMID 22855928
41: Gatheridge BJ, Miltenberger RG, Huneke DF, et al. Comparison of two programs to teach firearm injury prevention skills to 6-and 7-year-old children. Pediatrics 2004;114(3):e294-9. PMID 15342889
42: Glinge C, Rossetti S, Oestergaard LB, et al. Risk of sudden infant death syndrome among siblings of children who died of sudden infant death syndrome in Denmark. JAMA Netw Open 2023;6(1):e2252724. PMID 36696110
43: Goldstein RD, Petty CR, Morris SE, et al. Transitional objects of grief. Compr Psychiatry 2020;98:152161. PMID 31978784
44: Goldwater PN, Kelmanson IA, Little BB. Increased thymus weight in sudden infant death syndrome compared to controls: the role of sub-clinical infections. Am J Hum Biol 2021;33(6):e23528. PMID 33107139
45: Guntheroth WG. The thymus, suffocation, and the sudden infant death syndrome--social agenda or hubris? Perspect Biol Med 1993;37:2-13. PMID 8265334
46: Guntheroth WG. Crib death: sudden infant death syndrome. 3rd ed. Mt. Armonk, New York: Futura, 1995.
47: Guntheroth WG, Lohmann R, Spiers PS. Risk of sudden infant death syndrome in subsequent siblings. J Pediatr 1990;116:520-4. PMID 2319397
48: Guntheroth WG, Spiers PS. Sleeping prone and the risk of sudden infant death syndrome. JAMA 1992b;267:2359-62. PMID 1564777
49: Guntheroth WG, Spiers PS. The triple risk hypotheses in sudden infant death syndrome. Pediatrics 2002;110:e64. PMID 12415070
50: Guntheroth WG, Spiers PS. Sudden infant death syndrome and brain abnormalities. JAMA 2007:297:1190. PMID 17374807
51: Guntheroth WG, Spiers PS, Naeye RL. Redefinition of sudden infant death syndrome: the disadvantages. Pediatr Pathol 1994;14:127-32. PMID 8159610
52: Hauck FR, McEntire BL, Raven LK, et al. Research priorities in sudden unexpected infant death: an international consensus. Pediatrics 2017;140(2):e20163514. PMID 28751613
53: Haynes RL, Folkerth RD, Paterson DS, et al. Serotonin receptors in the medulla oblongata of the human fetus and infant: the analytic approach of the International Safe Passage Study. J Neuropathol Exp Neurol 2016;75(11):1048-57. PMID 27634962
54: Haynes RL, Trachtenberg F, Darnall R, et al. Altered 5-HT2A/C receptor binding in the medulla oblongata in the sudden infant death syndrome (SIDS): Part I. Tissue-based evidence for serotonin receptor signaling abnormalities in cardiorespiratory- and arousal-related circuits. J Neuropathol Exp Neurol 2023;82(6):467-82. PMID 37226597
55: Helweg-Larsen K, Lundemose JB, Oyen N, et al. Interactions of infectious symptoms and modifiable risk factors in sudden infant death syndrome. The Nordic Epidemiological SIDS study. Acta Paediatr 1999;88(5):521-7. PMID 10426174
56: Horne RS, Bandopadhayay P, Vitkovic J, Cranage SM, Adamson TM. Effects of age and sleeping position on arousal from sleep in preterm infants. Sleep 2002;25(7):746-50. PMID 12405610
57: Huang J, Waters KA, Machaalani R. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor 1 (PAC1) in the human infant brain and changes in the sudden infant death syndrome (SIDS). Neurobiol Dis 2017;103:70-7. PMID 28392470
58: Jensen LL, Rohde MC, Banner J, Byard RW. Reclassification of SIDS cases—a need for adjustment of the San Diego classification. Int J Legal Med 2012;126(2):271-7. PMID 22037935
59: Jiang RY, Varughese RT, Kothare SV. Sudden unexpected death in epilepsy: a narrative review of mechanism, risks, and prevention. J Clin Med 2025;14(10):3329. PMID 40429323
60: Kanno S, Fukuta M, Kato H, Monma-Otaki J, Nakamura Y, Oshima T. Comparative analysis of microRNA expression in serum-derived extracellular vesicles from sudden infant death syndrome cases. Sci Rep 2026;16(1):8168. PMID 41667630
61: Katz D, Shore S, Bandle B, Niermeyer S, Bol KA, Khanna A. Sudden infant death syndrome and residential altitude. Pediatrics 2015;135(6):e1442-9. PMID 26009621
62: Kelmanson IA. Differences in somatic and organ growth rates in infants who died of sudden infant death syndrome. J Perinat Med1992;20(3):183-8. PMID 1453291
63: Kinney HC. Abnormalities of the brainstem serotonergic system in the sudden infant death syndrome: a review. Pediatr Dev Pathol 2005;8(5):507-24. PMID 16222475
64: Kinney HC, Filiano JJ, White WF. Medullary serotonergic network deficiency in the sudden infant death syndrome: review of a 15-year study of a single dataset. J Neuropathol Exp Neurol 2001;60(3):228-47. PMID 11245208
65: Kinney HC, Folkerth RD, Nelson ME, et al. Serotonergic receptor binding in the brainstem in the sudden infant death syndrome in a high-risk population. PLoS One 2025;20(9):e0330940. PMID 40929069
66: Kochen EM, Jenken F, Boelen PA, et al. When a child dies: a systematic review of well-defined parent-focused bereavement interventions and their alignment with grief- and loss theories. BMC Palliat Care 2020;19(1):28. PMID 32164668
67: Kotta MC, Torchio M, Bayliss P, et al. Cardiac genetic investigation of sudden infant and early childhood death: a study from victims to families. J Am Heart Assoc 2023;12(17):e029100. PMID 37589201
68: Lavezzi AM, Ferrero S, Roncati L, Matturri L, Pusiol T. Impaired orexin receptor expression in the Kolliker-Fuse nucleus in sudden infant death syndrome: possible involvement of this nucleus in arousal pathophysiology. Neurol Res 2016;38(8):706-16. PMID 27353953
69: Lei F, Yan X, Zhao F, et al. Impairment of central chemoreception in neonatal rats induced by maternal cigarette smoke exposure during pregnancy. PLoS One 2015;10(9):e0137362. PMID 26333001
70: Liebrechts-Akkerman G, Bovée JV, Wijnaendts LC, Maes A, Nikkels PG, deKrijger RR. Histological findings in unclassified sudden infant death, including sudden infant death syndrome. Pediatr Dev Pathol 2013;16(3):168-76. PMID 23331080
71: Machaalani R, Say M, Waters KA. Serotoninergic receptor 1A in the sudden infant death syndrome brainstem medulla and associations with clinical risk factors. Acta Neuropathol 2009;117(3):257-65. PMID 19052756
72: MacLean JE, Fitzgerald DA, Waters KA. Developmental changes in sleep and breathing across infancy and childhood. Paediatr Respir Rev 2015;16(4):276-84. PMID 26364005
73: Mage DT, Donner EM. The fifty percent male excess of infant respiratory mortality. Acta Paediatr 2004;93(9):1210-5. PMID 15384886
74: Malloy MH. Prematurity and sudden infant death syndrome: United States 2005-2007. J Perinatol 2013;33(6):470-5. PMID 23288251
75: Malloy MH. Size for gestational age at birth: impact on risk for sudden infant death and other causes of death. Arch Dis Child Fetal Neonatal Ed 2007;92(6):F473-8. PMID 17314115
76: Mannikko R, Wong L, Tester DJ, et al. Dysfunction of NaV1.4, a skeletal muscle voltage-gated sodium channel, in sudden infant death syndrome: a case-control study. Lancet 2018;391(10129):1483-92. PMID 29605429
77: Maron BJ, Clark CE, Goldstein RE, Epstein SE. Potential role of QT interval prolongation in sudden infant death syndrome. Circulation 1976;54(3):423-30. PMID 947572
78: McGarvey C, McDonnell M, Hamilton K, O'Regan M, Matthews T. An 8 year study of risk factors for SIDS: bed-sharing versus non-bed-sharing. Arch Dis Child 2006;91(4):318-23. PMID 16243855
79: McGuone D, Crandall LG, Devinsky O. Sudden unexplained death in childhood: a neuropathology review. Front Neurol 2020;11:582051. PMID 33178125
80: Miklas JW, Clark E, Levy S, et al. TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes. Nat Commun 2019;10(1):4671. PMID 31604922
81: Mitchell EA, Taylor BJ, Ford RP, et al. Dummies and the sudden infant death syndrome. Arch Dis Child 1993;68(4):501-4. PMID 8503676
82: Moon RY, Task Force On Sudden Infant Death Syndrome. SIDS and other sleep-related infant deaths: evidence base for 2016 updated recommendations for a safe infant sleeping environment. Pediatrics 2016;138(5). PMID 27940805
83: Moon RY, Carlin RF, Hand I, Task Force On Sudden Infant Death Syndrome and the Committee On Fetus and Newborn. Sleep-related infant deaths: updated 2022 recommendations for reducing infant deaths in the sleep environment. Pediatrics 2022;150(1). PMID 35726558
84: Morse AM, Kothare SV. Pediatric sudden unexpected death in epilepsy. Pediatr Neurol 2016;57:7-16. PMID 26850125
85: Muller-Starck J, Büttner A, Kiessling MC, et al. No changes in cerebellar microvessel length density in sudden infant death syndrome: implications for pathogenetic mechanisms. J Neuropathol Exp Neurol 2014;73(4):312-23. PMID 24607967
86: October T, Dryden-Palmer K, Copnell B, Meert KL. Caring for parents after the death of a child. Pediatr Crit Care Med 2018;19(8S Suppl 2):S61-8. PMID 30080812
87: Opdal SH, Rognum TO. The sudden infant death syndrome gene: does it exist? Pediatrics 2004;114(4):e506-12. PMID 15466077
88: Opdal SH, Vege Å, Rognum TO. Genetic variation in the monoamine oxidase A and serotonin transporter genes in sudden infant death syndrome. Acta Paediatr 2014;103(4):393-7. PMID 24286237
89: Opdal SH, Vege A, Stave AK, Rognum TO. The complement component C4 in sudden infant death. Eur J Pediatr 1999;158(3):210-2. PMID 10094440
90: Oltman SP, Rogers EE, Baer RJ, et al. Early newborn metabolic patterning and sudden infant death syndrome. JAMA Pediatr 2024;178(11):1183-91. PMID 39250160
91: Parks SE, Erck Lambert AB, Shapiro-Mendoza CK. Racial and ethnic trends in sudden unexpected infant deaths: United States, 1995-2013. Pediatrics 2017;139(6). PMID 28562272
92: Paterson DS, Trachtenberg FL, Thompson EG, et al. Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA 2006;296(17):2124-32. PMID 17077377
93: Ramachandran PS, Okaty BW, Riehs M, et al. Multiomic analysis of neuroinflammation and occult infection in sudden infant death syndrome. JAMA Neurol 2024;81(3):240-247. PMID 38285456
94: Rechtman LR, Colvin JD, Blair PS, Moon RY. Sofas and infant mortality. Pediatrics 2014;134(5):e1293-300. PMID 25311597
95: Rimsza ME, Newberry S. Unexpected infant deaths associated with use of cough and cold medications. Pediatrics 2008;122:e318-22. PMID 18676517
96: Rognum IJ, Haynes RL, Vege A, Rognum TO, Kinney HC. Interleukin-6 and the serotonergic system of the medulla oblongata in the sudden infant death syndrome. Acta Neuropathol 2009;118(4):519-30. PMID 19396608
97: Rognum IJ, Tran H, Haas EA, et al. Serotonin metabolites in the cerebrospinal fluid in sudden infant death syndrome. J Neuropathol Exp Neurol 2014;73(2):115-22. PMID 24423636
98: Santori M, Blanco-Verea A, Gil R, et al. Broad-based molecular autopsy: a potential tool to investigate the involvement of subtle cardiac conditions in sudden unexpected death in infancy and early childhood. Arch Dis Child 2015;100(10):952-6. PMID 26272908
99: Sawaguchi T, Ozawa Y, Franco P, et al. Serotonergic receptors in the midbrain correlated with physiological data on sleep apnea in SIDS victims. Early Hum Dev 2003;75:S65-74. PMID 14693393
100: Say M, Machaalani R, Waters KA. Changes in serotoninergic hypoxia 1A and 2A in the piglet brainstem after intermittent hypercapnic hypoxia (IHH) and nicotine. Brain Res 2007;1152:17-26. PMID 17451658
101: Scherdel P, Ricard A, Gras-le Guen C, et al. Impact of COVID-19 pandemic interventions on sudden unexpected death in infancy incidence in France. J Pediatr 2025;277:114369. PMID 39433153
102: Schneider PM, Wendler C, Riepert T, et al. Possible association of sudden infant death with partial complement C4 deficiency revealed by post-mortem DNA typing of HLA class II and III genes. Eur J Pediatr 1989;149(3):170-4. PMID 2612504
103: Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998;338:1709-14. PMID 9624190
104: Sergeev V, Perry F, Roston TM, Sanatani S, Tibbits GF, Claydon TW. Functional characterization of a novel hERG variant in a family with recurrent sudden infant death syndrome: retracting a genetic diagnosis. Forensic Sci Int 2018;284:39-45. PMID 29331839
105: Shapiro-Mendoza CK, Parks SE, Brustrom J, et al. Variations in cause-of-death determination for sudden unexpected infant deaths. Pediatrics 2017;140(1):e20170087. PMID 28759406
106: Spinelli J, Byard RW, Van Den Heuvel C, Collins-Praino LE. Medullary astrogliosis in sudden infant death syndrome varies with sleeping environment: evidence for different mechanisms of death in alone versus co-sleepers? J Child Neurol 2018;33(4):269-74. PMID 29357731
107: St-John WM, Li A, Leiter JC. Genesis of gasping is independent of levels of serotonin in the Pet-1 knockout mouse. J Appl Physiol 2009;107(3):679-85. PMID 19213935
108: Subramonian A, Featherstone R. Interventions for the prevention of sudden infant death syndrome and sudden unexplained death in infancy: a review of guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health 2020. PMID 33439597
109: Thompson JMD, Tanabe K, Moon RY. Duration of breastfeeding and risk of SIDS: an individual participant data meta-analysis. Pediatrics 2017;140(4). PMID 29084835
110: Tonkin SL, Lui D, McIntosh CG, Rowley S, Knight DB, Gunn AJ. Effect of pacifier use on mandibular position in preterm infants. Acta Paediatr 2007;96(10):1433-6. PMID 17714544
111: van Rijt WJ, Koolhaas GD, Bekhof J, Kruizinga MD, Schielen PC, de Vries M, et al. Inborn errors of metabolism that cause sudden infant death: a systematic review with implications for population neonatal screening programmes. Neonatology 2016;109(4):297-302. PMID 26907928
112: Vennemann MM, Hoffgen M, Bajanowski T, Hense HW, Mitchell EA. Do immunizations reduce the risk of SIDS. A meta-analysis. Vaccine 2007;25(26):4875-9. PMID 17400342
113: Waggener TB, Southall DP, Scott LA. Analysis of breathing patterns in a prospective population of term infants does not predict susceptibility to sudden infant death syndrome. Pediatr Res 1990;27:113-7. PMID 2314938
114: Ward TC, Balfour GM. Infant safe sleep interventions, 1990–2015: A review. J Community Health 2016;41(1):180-96. PMID 26143241
115: Whitney R, Sharma S, Ramachandrannair R. Sudden unexpected death in epilepsy in children. Dev Med Child Neurol 2023;65(9):1150-6. PMID 36802063
116: Wiener L, Rosenberg AR, Lichtenthal WG, Tager J, Weaver MS. Personalized and yet standardized: an informed approach to the integration of bereavement care in pediatric oncology settings. Palliat Support Care 2018;16(6):706-11. PMID 29386073
117: Wigfield RE, Fleming PJ, Berry PJ, Rudd PT, Golding J. Can the fall in Avon's sudden infant death rate be explained by changes in sleeping position? BMJ 1992;304(6822):282-3. PMID 1739827
118: Wilders R. Cardiac ion channelopathies and the sudden infant death syndrome. ISRN Cardiology 2012;2012:846171. PMID 23304551
119: Winkel BG, Yuan L, Olesen MS, et al. The role of the sodium current complex in a nonreferred nationwide cohort of sudden infant death syndrome. Heart Rhythm 2015;12(6):1241-9. PMID 25757662
120: Zenteno-Araos D, Díaz-Silva J, Brockmann-Veloso P. [Application of a new terminology "BRUE: brief, resolved and unexplained events". Definitions and recommendations]. Rev Chil Pediatr 2020;91(3):424-31. PMID 32730525
121: Zhang K, Wang X. Maternal smoking and increased risk of sudden infant death syndrome: a meta-analysis. Leg Med (Tokyo) 2013;15(3):115-21. PMID 23219585

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Authors

Sanjeev V Kothare MD FAES FAAN FAASM

Dr. Kothare of Cohen Children’s Medical Center and Zucker School of Medicine at Hofstra/Northwell has no relevant financial relationships to disclose.
See Profile
Joel Willard MD

Dr. Willard of Cohen Children's Medical Center in New York has no relevant financial relationships to disclose.
See Profile

Editor

Antonio Culebras MD FAAN FAHA FAASM

Dr. Culebras of SUNY Upstate Medical University at Syracuse has no relevant financial relationships to disclose.
See Profile

Former Authors

Philip S Spiers PhD
Warren G Guntheroth MD
Pallavi P Patwari MD
Ryan Coates MD
Darius A Loghmanee MD
Matthew Balog MPH
Usha S Appalaneni MD
Lourdes M DelRosso MD PhD
Michelle Y Sobremonte-King MD

Patient Profile

Age range of presentation: 0 to 12 months
Sex preponderance: male>female, >1:1, excess of 50% (Mage and Donner 2004)
Heredity: none
Population groups selectively affected: African Americans

Native Americans
Occupation groups selectively affected: none selectively affected

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Sudden infant death syndrome

Associated Disorders

Autonomic dysregulation

Differential Diagnosis

suffocation
infection
arrhythmia
trauma
metabolic disease
- entrapment
- asphyxia
- cystic fibrosis
- hepatitis
- encephalitis
- arteriovenous malformation with hemorrhage
- congenital adrenal hyperplasia
- pulmonary hypertension
- congenital heart disease
- myocarditis
- sepsis
- bronchiolitis
- pneumonia
- meningitis
- enterocolitis
- metabolic diseases
- child abuse

Also Relevant

Child maltreatment
Malformations of the brain
Obstructive sleep apnea
Sudden unexpected death in epilepsy
Sudden unexplained nocturnal death syndrome

Sudden infant death syndrome

Cite this article

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Table 1. Risk Factors Potentially Amenable to Intervention in SIDS

Differential diagnosis

Diagnostic workup

Management

Outcomes

Special considerations

Pregnancy

Anesthesia

References

Contributors

Authors

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Sleep-related leg cramps

Congenital heart disease: neurologic complications

Acute cerebellar ataxia in children

Febrile seizures

Congenital lymphocytic choriomeningitis virus infection

Ataxia-telangiectasia

Self-limited (familial) infantile epilepsy

Developmental delay in children: evaluation and management

This is an article preview.
Start a Free Account
to access the full version.